2040 KB11 KB199220252000Krajnc, IvanLukanovič, KamiloPrelog, Idaštevilka:3letnik:9str. 110-112COBISSID:12158425ISSN:1318-4458URN:URN:NBN:SI:doc-BXVNPIANenSlovene Welding SocietyActa dermatovenerologica Alpina, Pannonica et AdriaticaArthritis, psoriaticCyclosporineDrug therapypsoriatični artritisTreatment outcomezdravljenjeTreatment of psoriatic arthritis with cyclosporin A|The purpose of this study was to determine the efficacy and toxicity of cyclosporin A (CsA) in treatment of patients affected with psoriatic arthritis(PsA). Methods: This study includes 11 patients with PsA. Clinical and functional parameters are assessed: Ritchie Index, duration of the morningstiffness of joints in minutes, and pain. Laboratory values in serum were checked: SR, CRP, urea, creatinin, cholesterol, trigliceride, electrolyte, and liver enzymes. Measurements of blood pressure were taken monthly. Results: With a therapeutic dose of CsA 3 mg/kg/daily we noticed an improvement of clinical parameters, but not of laboratory values. Conclusion: The investigation showed that CsA in the dosis of 3 mg/kg/daily was efficient and safe in the treatment of PsATEXTznanstveno časopisjejournalsSlovenian National E-content AggregatorNational and University Library of SloveniaZdruženje slovenskih dermatovenerologov